Results 241 to 250 of about 4,725,282 (330)

Estudio de 258 prematuros en el primer año de la vida [PDF]

open access: gold, 1941
OSCAR ILLANES BENITEZ   +1 more
openalex   +1 more source

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary: This randomized trial was designed to test the effectiveness and safety of rimegepant for the acute treatment of migraine among adults in Japan. Results indicated that rimegepant was more effective than placebo, and the 75 mg dose was observed to be more effective than the 25 mg dose.
Koichi Ikeda   +11 more
wiley   +1 more source

Spirituality and health-related quality of life in patients with lung cancer. [PDF]

open access: yesRev Bras Enferm
Santos EMBD   +7 more
europepmc   +1 more source

Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double‐blind, randomized controlled trial

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary: This study tested the effectiveness of rimegepant for migraine prevention in Japan. Results showed that rimegepant was more effective than placebo in reducing monthly migraine days, with very few adverse effects. These results support the previous findings from a clinical study conducted in the United States and broaden them to ...
Shigekazu Kitamura   +11 more
wiley   +1 more source

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow   +3 more
wiley   +1 more source

[Exploring the Connection Between Pain, Age, Sex, Quality of Life, Functional Capacity, And Sleep: An Analysis in Community Pharmacy].

open access: yesFarm Comunitarios
Reyes Estévez D   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy